Vaccinated pregnant ladies pass significant degree of antibodies to infants: Study Kumar Jeetendra | September 23, 2021 Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, according to a study. The effectiveness of COVID-19 vaccines lies in their ability to trigger the production of the right antibodies, blood proteins capable of protecting individuals from infection, researchers said. Whether this protection could pass from mothers to …
Queen Elizabeth Hospital King’s Lynn invented device awarded HSJ Patient Safety Innovation of the Year Kumar Jeetendra | September 23, 2021 A ground-breaking regional anaesthesia device, invented by clinicians at The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust (QEH) and developed in conjunction with medical device company Medovate, has been awarded ‘Patient Safety Innovation of the Year’ at this year’s HSJ Patient Safety Awards. The HSJ Patient Safety Awards celebrated the innovative work of frontline …
Scientists find how Rift Valley fever virus enters cells Kumar Jeetendra | September 24, 2021 Rift Valley fever virus causes economically tragic hemorrhagic outbreaks in livestock, including cattle, goats, and sheep. The mosquito-borne infections can lead to the spread of infection to people who work with animals that are dying or dead often causing many human infections as well as many deaths. Rift Valley fever, for which there isn’t a …
Small molecule drug can weaken the triggers of neuroinflammation, preclinical review shows Kumar Jeetendra | September 24, 2021 Neuroinflammation may cause worse outcomes in cases of stroke, injuries to the brain or injury, and can increase the severity of neurodegenerative diseases such as ALS, Parkinson’s, or Alzheimer’s. This suggests that reducing neuroinflammation might be an exciting new method to treat neurological disorders and neuropathic pain caused by neuroinflammation. In a preclinical study , …
Study recognizes master regulator behind the improvement of antibody delivering cells Kumar Jeetendra | September 24, 2021 The main regulator that controls the production of antibody-producing cells was identified in a research conducted by scientists from Weill Cornell Medicine. These findings offer new insights into the functioning in the immunity system. It also can help to understand how tissues form and how cancers are triggered. The study, which was published on September. …
Determining Optimum Ceramic Materials for BioMedical Applications Kumar Jeetendra | September 24, 2021 The Bl-200SM research goniometer system from TESTA Analytical Solutions e.K. provides unmatched performance and operational versatility for Static Light Scattering (SLS) and Dynamic Light Scattering (DLS) studies. Researchers from Eötvös Loránd University, the oldest and largest university in Hungary, have used a BI-200SM in Dynamic Light Scattering mode to determine the aggregate size of powders …
Industrial chemical perfluorobutanoic acid less inclined to aggregate in human lungs and kidneys Kumar Jeetendra | September 25, 2021 A 2013 study by Perez et al. discovered a significant accumulation of the chemical used in industrial production, perfluorobutanoic Acid (PFBA) in the human kidneys and lungs. Researchers from the German Federal Institute for Risk Assessment (BfR) examined the results with an even more precise method for quantification. The resultwas that only one sample had …
Novel antibody candidate shows powerful binding to different SARS-CoV-2 variant mutations Kumar Jeetendra | September 25, 2021 Twist Bioscience Corporation today reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to diverse SARS-CoV-2 variant mutations, including strains with the E484K, N501Y, D614G, Y453F and K417N mutations in pseudovirus assays, indicating this therapeutic antibody may be effective in treating many strains of COVID-19. The Coronavirus Immunotherapy Consortium (CoVIC) is an academic-industry-non-profit …
Pfizer starts investigation of oral drug for counteraction of COVID-19 Kumar Jeetendra | September 27, 2021 Pfizer Inc said on Monday it has started a mid-to-late-stage study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus. The company and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG, have been racing to develop the …
Xuanzhu and SignalChem Lifesciences Corporation Announce Collaboration and Licensing Agreement for SLC-391 in the Greater China Region Kumar Jeetendra | September 27, 2021 September 27, 2021 – Beijing, China and Richmond, British Columbia, Canada – Life Science Newswire – Sihuan Pharmaceutical Holdings Group Ltd., together with its subsidiaries and SignalChem Lifesciences Corporation today announced that Sihuan Pharmaceutical Holdings Group Ltd subsidiary company Xuanzhu Biopharmaceutical Co., Ltd. (“Xuanzhu”) and SignalChem Lifesciences Corporation (“SignalChem”) have entered into an exclusive collaboration …
US representative commends India’s choice to continue COVID-19 vaccination export Kumar Jeetendra | September 30, 2021 A top Republican senator on Tuesday welcomed India’s decision to resume the export of COVID-19 vaccines. Senator Jim Risch, ranking member of the Senate Foreign Relations Committee, also urged India to increase the production of such vaccines so that it can meet its international obligations. “I welcome the announcement by #India that it will restart …
Environment Research & Heavy Metals: A Toxic Relationship Kumar Jeetendra | September 30, 2021 What are heavy metals? Heavy metals are naturally occurring elements & are a group of metals and metalloids that have relatively high density and are toxic even at ppb levels. Examples include Pb, As, Hg, Cd, Zn, Ag, Cu, Fe, Cr, Ni, Pd, and Pt. Multiple industrial, domestic, agricultural, medical and technological applications have led …
